Hypothalamic Lymphoma



Fig. 15.1
Enhanced CT scan on axial view (a) and sagittal T2-weighted MRI (b) showing a bilateral hypothalamic lymphoma with suprasellar extension, optic chiasm infiltration and brainstem involvement



A303967_1_En_15_Fig2_HTML.jpg


Fig. 15.2
Axial (a) and sagittal coronal (b) T1-weighted MRIs with gadolinium infusion demonstrate a suprasellar-hypothalamic lymphoma with bifrontal extension


It’s well known that if a CNS lymphoma is suspected, administration of corticosteroids therapy should be delayed until a definitive biopsy has been performed.

The differential diagnosis of a hypothalamic mass includes craniopharyngioma, Rathke cleft cyst, germ cell tumour, granulomatous processes, glioma, hamartoma, germinoma and aneurysm (Samuels and de la Monte 1994; Akhaddar et al. 2001, 2011; Oweity et al. 2002; Chourmouzi et al. 2005; Binning et al. 2008; Rennert J and Doerfler 2007; Raoa et al. 2008; Fadoukhair et al. 2010; Belfquih et al. 2012).

Craniopharyngioma has a heterogeneous appearance with solid and cystic elements tumour in the suprasellar region. Rathke cleft cysts usually have the following imaging features: a sellar epicentre, smooth contour, lack of calcification, lack of internal enhancement and a homogeneous signal intensity within the lesion. The characteristic features of granulomatous diseases are thickening of the pituitary stalk and absence of a normal bright posterior pituitary signal. Imaging of germ cell tumour shows generally an infiltrative, solid, homogeneous mass in the midline with intense contrast enhancement. Hypothalamic glioma tends to be solid with microcyst formation and is iso- or hypointense on T1-weighted images, hyperintense on T2-weighted images and demonstrates enhancement with contrast. Hypothalamic hamartoma presents as precocious puberty in a young child with a nodular mass in the suprasellar cistern. The mass is isointense with normal brain on T1-weighted images and isointense or mild hyperintense on T2-weighted images. These lesions usually do not enhance after contrast administration. Suprasellar germinoma appears as a well-marginated lobulated homogeneous tumour with prolonged T1 and T2 relaxation times which strongly enhances after gadolinium administration. The presence of these imaging findings along with the presence of diabetes insipidus and a suprasellar mass is a clue to the diagnosis of germinoma. Although metastatic tumour could not be ruled out, absence of any primary malignancy on chest, abdominal and pelvic computed tomography scan (CT scan) made it unlikely. Aneurysms of the sellar region usually originate from the cavernous or supraclinoid portions of the internal carotid artery and account for up to 10 % of all cerebral aneurysms. In selected cases, they can mimic other supra-, para- or intrasellar lesions. MRI or CT scan is useful in differentiating tumour from thrombosed and nonthrombosed aneurysms.

The differential diagnosis of primary versus secondary CNS lymphomas may include a complete neurological staging, including cerebrospinal fluid examination and ophthalmological evaluation with slit-lamp examination to exclude vitreous or retinal involvement. In addition, an abdominopelvic CT scan and bone marrow biopsy may be obtained to exclude systemic lymphoma (Giustina et al. 2001).



15.6 Pathology


Histologically, hypothalamic lymphomas are similar to other CNS lymphomas: predominant B-cell non-Hodgkin lymphoma. In our review of 15 reports of patients with hypothalamic lymphoma, 2 did not provide detailed histological description (Patrick et al. 1989; Schwingel et al. 2011), and 13 were B-cell immunophenotype which 2 patients had Burkitt’s lymphoma (Table 15.1).


15.7 Treatment and Outcome


The management of hypothalamic lymphoma is multimodal requiring judicious use of observation, surgery, chemotherapy, radiotherapy and hormone substitution. The initial challenge is establishment of the diagnosis by surgical biopsy: open or stereotactic to differentiate from other suprasellar tumours. Most patients underwent surgical biopsy through stereotactic approach.

In our review, treatments were not observed in three cases, four received chemotherapy alone and one patient received radiotherapy alone. Chemotherapy followed by radiotherapy was performed in four cases. It seems that in immunocompetent patients treated with chemotherapy followed by radiotherapy have considerable improvements in survival (Hobson et al. 1986; Patrick et al. 1989; Jonkhoff et al. 1993; Pioltelli et al. 1996; Lee et al. 2004). Regimens used were different and were in the most cases extrapolated from the protocol used in CNS lymphoma. Despite the increasing number of studies published since a decade on CNS lymphoma and recent therapeutic advances, several questions still remain unanswered about the optimal management of these unusual tumours.

Treatment of immunocompromised patients is aimed at reversing the immunosuppression. If it is reversed, the tumour may regress. In patients with AIDS-associated primary CNS lymphoma, therapy of this type is not possible and the prognosis is very poor as with secondary CNS lymphoma (Samuels and de la Monte 1994).

We attempted to clarify the relationship between treatments and prognosis. However, the treatments varied case by case. In addition, in many reports, the description of clinical outcomes was limited (Matsuda et al. 1999).


Conclusion


Hypothalamic lymphoma is a rare but an increasing clinical entity in recent epidemiological data. It may be a primary tumour or after spreading from an established systemic lymphoma. The clinical presentations are always atypical. Acute presentation may mimic a pituitary apoplexy. MRI findings are largely nonspecific and the tumours are rarely limited to the hypothalamic area. The definite diagnosis depends on histopathologic description. The more common immunophenotype are B-cell non-Hodgkin lymphoma. The overall outcome is favourable with significant survival. Early diagnosis and prompt treatment combination of surgery, chemotherapy, radiation therapy and hormonal substitution can ensure maximal quality of life over the long term. Great attention must be paid to the lasting morbidity associated with pituitary/hypothalamic insufficiencies.


Table 15.1
Summary of demographic data, clinical presentation, imaging characteristics, histopathologic findings, therapy and outcomes of the 15 cases with hypothalamic lymphoma reported in the literature since 1988












































































Author/year

Sex, age

Primary or secondary localization

Pituitary dysfunction

Neurological dysfunction

Affected sites

Histopathology findings

Treatment

Follow-up/outcome

Patrick/1989

F, 30 y

Primary

Anterior and posterior

Ataxic with spasticity, hyperreflexia and diminished vibration sensation in the lower limbs

Normal CT scan

Autopsy: cerebellum, thalamus, cingulated gyri and hypothalamus

Lymphoma (autopsy)

Corticosteroids

No clinical response.

Died 26 months after onset

Balmaceda/1994

M, 65 y

Primary

Anterior

Declined cognitive function and urinary incontinence

Multiple lesions in lateral, third ventricles, right thalamus, hypothalamus and cerebellum

B-cell lymphoma

Kappa light chain immunoglobulin (Stereotactic biopsy)

Intraventricular chemotherapy, systemic chemotherapy

Radiotherapy

Clinical improvement

Normal pressure hydrocephalus

Recurrence 22 months later

Samuels/1994

M, 49 y

Primary

Anterior and posterior

Headache, diminished hearing, blurred vision, visual field defect, dysarthria, gait difficulty

Cold intolerance

Hypothalamic lesion (20 mm) with extension to suprasellar cistern and optic chiasm

B-cell lymphoma

Kappa light chain immunoglobulin (Stereotactic biopsy)

Chemotherapy (6 cycles of methotrexate)

Hormonal therapy replacement

Clinical improvement

Complete resolution of the mass

Silfen/2001

M, 15 y

Primary (Family history of leukaemia, sarcoma and a brain tumour)

Anterior and posterior


Nine mm lesion in region of pituitary stalk

B-cell lymphoma suggestive of Burkitt’s lymphoma

Intrathecal chemotherapy (methotrexate) and cytarabine, prednisone, vincristine, cyclophosphamide, doxorubicin and hydrocortisone

Hormonal therapy replacement

Clinical improvement

Complete mass resolution after 11 months

Remission for 17 months

Lee/2004

M, 64 y

Primary

Anterior

Hyperprolactinemia

Stiff-man syndrome and visual field defect

Hypothalamic tumour (18 mm) with optic chiasm involvement

B-cell lymphoma (Partial resection)

Radiotherapy

Hormonal therapy replacement

Clinical improvement

Complete mass resolution after 1 year

No recurrence after 2 years

Chourmouzi/2005

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Sep 26, 2017 | Posted by in GENERAL & FAMILY MEDICINE | Comments Off on Hypothalamic Lymphoma

Full access? Get Clinical Tree

Get Clinical Tree app for offline access